Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology, cardiology, neurology, and inherited diseases through advanced diagnostic technologies, products and services. Its ultra-sensitive ICE COLD-PCR™ powers the company’s liquid biopsy analyses that can be run on any sequencing platform to deliver a comprehensive genomic profile that includes all mutations. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies.
Trading Information Stock Price History Beta: 0.21 52-Week Change3: -66.48% S&P500 52-Week Change3: -0.14% 52-Week High (May 29, 2015)3: 3.75 52-Week Low (Feb 23, 2016)3: 0.49 50-Day Moving Average3: 0.64 200-Day Moving Average3: 0.82 Share Statistics Avg Vol (3 month)3: 105,727 Avg Vol (10 day)3: 72,800 Shares Outstanding5: 20.70M Float: 8.41M % Held by Insiders1: 18.61% % Held by Institutions1: 12.60% Shares Short (as of Mar 31, 2016)3: 435.66K Short Ratio (as of Mar 31, 2016)3: 2.10 Short % of Float (as of Mar 31, 2016)3: 3.83% Shares Short (prior month)3: 433.53K
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.